Blue Bell, PA, United States of America

Angel Morales-Ramos

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Vitae Pharmaceuticals, Inc., Boehringer Ingelheim International Gmbh. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angel Morales-Ramos. Retrieved from https://idiyas.com/inventor/angel-morales-ramos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 76.9

 

 

Average Co-Inventor Count = 14.0

ph-index = 4

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Angel Morales-Ramos: Innovator in Cancer Treatment

Introduction

Angel Morales-Ramos, a distinguished inventor residing in Blue Bell, PA, holds an impressive portfolio of 13 patents. His pioneering work primarily focuses on the development of novel therapies aimed at treating various forms of cancer. With a rich background in pharmaceutical research and innovation, Morales-Ramos has made significant strides in enhancing the understanding and treatment of diseases mediated by specific molecular interactions.

Latest Patents

Among his most recent patents, Angel Morales-Ramos has concentrated on inhibitors of the menin-MLL interaction. This invention is particularly groundbreaking as it is directed towards inhibiting the interaction between menin and MLL, as well as MLL fusion proteins. The pharmaceutical compositions derived from this invention not only highlight the potential for innovative cancer treatments but also represent a promising avenue in the fight against various diseases linked to the menin-MLL interaction.

Career Highlights

Angel's career features notable positions within esteemed organizations such as Vitae Pharmaceuticals and Boehringer Ingelheim International GmbH. His involvement in these companies showcases his commitment to advancing pharmaceutical sciences and highlights his role in pushing the boundaries of medical innovation through his research and inventions.

Collaborations

Throughout his career, Angel has collaborated with a number of talented professionals, including colleagues like Salvacion Cacatian and Lanqi Jia. These partnerships have played a vital role in the development of his innovative ideas and inventions, underscoring the importance of teamwork in scientific research.

Conclusion

In conclusion, Angel Morales-Ramos stands out as a pivotal figure in the realm of cancer treatment innovation. With a robust portfolio of patents and a commitment to advancing pharmaceutical science, his contributions continue to impact the field significantly. His focus on the menin-MLL interaction not only opens new doors for cancer therapies but also illustrates the dynamic nature of research and invention in the fight against serious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…